Does letrozole cause iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Letrozole Cause Iron Deficiency?

No, letrozole does not cause iron deficiency. Iron deficiency is not listed as a known adverse effect of letrozole in the FDA drug label or clinical guidelines.

Evidence from FDA Drug Label

The comprehensive FDA prescribing information for letrozole 1 does not identify iron deficiency or anemia as adverse effects. The documented warnings and precautions for letrozole include:

  • Bone mineral density decreases (median 4.1% decrease in lumbar spine BMD at 24 months)
  • Elevated cholesterol (hypercholesterolemia in 52.3% of patients)
  • Hepatic effects requiring dose adjustment in severe impairment
  • Fatigue and dizziness
  • Laboratory abnormalities including moderate lymphocyte count decreases and rare thrombocytopenia

Notably absent from this list is any mention of iron deficiency, anemia, or effects on iron metabolism.

Clinical Context

The fatigue commonly reported with letrozole (mentioned in the case presentation 2 and FDA label 1) is not due to iron deficiency. This fatigue results from:

  • Estrogen suppression effects
  • Musculoskeletal symptoms (arthralgia/myalgia)
  • General medication side effects

If a patient on letrozole develops iron deficiency, investigate the actual causes of iron deficiency 3:

  • Gastrointestinal bleeding (especially in older patients)
  • Menstrual bleeding (if perimenopausal)
  • Dietary insufficiency
  • Malabsorption conditions
  • NSAID use (common in breast cancer survivors for pain management)

Clinical Pitfall to Avoid

Do not attribute iron deficiency to letrozole itself. If iron deficiency develops during letrozole therapy, pursue standard diagnostic evaluation including:

  • Serum ferritin (<30 ng/mL indicates deficiency)
  • Transferrin saturation (<20% indicates deficiency)
  • Evaluation for bleeding sources (GI workup, gynecologic assessment if applicable)
  • Assessment for malabsorption

The research literature on letrozole 4, 5, 6 extensively documents its effects on bone, lipids, and hormones but does not identify iron deficiency as a consequence of aromatase inhibition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.